33 |
CAR does not express |
Improper protein folding and/or trafficking of receptor to cell membrane |
Test multiple scFv sequences or ligand-binding domains (Fig. 2a). |
48 |
CAR-T cell does not signal |
Receptor affinity too low to transduce signal upon ligand binding. |
Test different scFv sequences or ligand-binding domains (Fig. 2b). Include positive control to test whether CAR responds to immobilized antigen. |
Poorly signaling CAR |
Control for ability of CAR to signal in a traditional manner using an immobilized antigen target (Fig. 2c). |
Poor T-cell product |
Control for ability of T cell to produce an effector response using PMA/ionomycin stimulation (Fig. 2c). |
8–33 |
Cell line with low viability |
Poor donor |
Test primary cells from multiple donors. |
Improper maintenance of T-cell cultures |
Maintain cultures at 1 × 106 cells per mL; supplement cultures with 50 U/mL IL-2 and 1 ng/mL IL-15 every 2–3 days. |
34–42 |
Poor yield from cell sorting |
Poor transduction efficiency |
Make sure transduction efficiency is sufficiently high (>20–30%) prior to sort (Supplementary Fig. 2). |
Positively transduced cells inadequately labeled |
Increase labeling time with antibody. |
51A |
Poor cell viability |
Brefeldin A toxicity |
Reduce incubation period in Brefeldin A. Depending on the exact measurement desired in the experiment, this can be performed by either shortening the incubation in 51Aiii to 4–12 hours, or initiating the experiment without Brefeldin A and adding Brefeldin A to cells 4–12 hours prior to completing the incubation. |
73 |
Cells touching when attempting to image without cell-cell contacts |
Cells are too dense |
Test various cell densities. |
74 |
Cells flow out of view after adding ligand to well when imaging |
Addition of ligand causes too much disturbance to wells |
Use higher concentration of ligand at smaller volume; apply ligand further away from region being imaged. |